This is a short guide outlining some of the key legal developments in the life sciences sector in 2013.
The developments include the Supreme Court decision on the patentability of human genes, policy-related statements on public websites, the inquiry by the French Competition Authority into the pharmaceutical sector, new regulations in the PRC and proposed changes for EU rules on technology licensing.
For further information or advice, please contact your usual contact at Mayer Brown or:
You have no pages selected. Please select pages to email then resubmit.